Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats

详细信息    查看全文

• 作者：Haidong Wei (1)
  Shiquan Wang (2)
  Luming Zhen (1)
  Qianzi Yang (2)
  Zhixin Wu (2)
  Xiaoming Lei (1)
  Jianrui Lv (1)
  Lize Xiong (2)
  Rongliang Xue (1)
  
  1. Department of Anesthesiology ; The Second Affiliated Hospital of Xi鈥檃n Jiaotong University ; Xi鈥檃n ; 710004 ; China
  2. Department of Anesthesiology ; Xijing Hospital ; Fourth Military Medical University ; Xi鈥檃n ; 710032 ; Shaanxi Province ; China
  
• 关键词：Resveratrol ; Cerebral ischemia ; Blood ; brain barrier ; Matrix metalloproteinase ; Tissue inhibitor of metalloproteinase
• 刊名：Journal of Molecular Neuroscience
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：55
• 期：4
• 页码：872-879
• 全文大小：1,287 KB
• 参考文献：1. Abbott, NJ, Ronnback, L, Hansson, E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: pp. 41-53 CrossRef
  2. Asahi, M, Asahi, K, Jung, JC, Del, ZG, Fini, ME, Lo, EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20: pp. 1681-1689 CrossRef
  3. Ashwal, S, Tone, B, Tian, HR, Cole, DJ, Pearce, WJ (1998) Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29: pp. 1037-1046 CrossRef
  4. Belayev, L, Busto, R, Ikeda, M, Rubin, LL, Kajiwara, A, Morgan, L, Ginsberg, MD (1998) Protection against blood鈥揵rain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study. Brain Res 787: pp. 277-285 CrossRef
  5. Belayev, L, Busto, R, Zhao, W, Fernandez, G, Ginsberg, MD (1999) Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res 833: pp. 181-190 CrossRef
  6. Brew, K, Dinakarpandian, D, Nagase, H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: pp. 267-283 CrossRef
  7. Chen, HY, Chen, TY, Lee, MY, Chen, ST, Hsu, YS, Kuo, YL, Chang, GL, Wu, TS, Lee, EJ (2006) Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 41: pp. 175-182 CrossRef
  8. Chen, F, Radisky, ES, Das, P, Batra, J, Hata, T, Hori, T, Baine, AM, Gardner, L, Yue, MY, Bu, G, Del, ZG, Patel, TC, Nguyen, JH (2013) TIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure. J Cereb Blood Flow Metab 33: pp. 1041-1049 CrossRef
  9. Cheng, G, Zhang, X, Gao, D, Jiang, X, Dong, W (2009) Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 451: pp. 105-108 CrossRef
  10. Desilles, JP, Rouchaud, A, Labreuche, J, Meseguer, E, Laissy, JP, Serfaty, JM, Lapergue, B, Klein, IF, Guidoux, C, Cabrejo, L, Sirimarco, G, Lavallee, PC, Schouman-Claeys, E, Amarenco, P, Mazighi, M (2013) Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology 80: pp. 844-851 CrossRef
  11. Dong, W, Gao, D, Lin, H, Zhang, X, Li, N, Li, F (2008) New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9. Med Hypotheses 70: pp. 52-55 CrossRef
  12. Dziembowska, M, Wlodarczyk, J (2012) MMP9: a novel function in synaptic plasticity. Int J Biochem Cell Biol 44: pp. 709-713 CrossRef
  13. Fujimoto, M, Takagi, Y, Aoki, T, Hayase, M, Marumo, T, Gomi, M, Nishimura, M, Kataoka, H, Hashimoto, N, Nozaki, K (2008) Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 28: pp. 1674-1685 CrossRef
  14. Garcia, JH, Wagner, S, Liu, KF, Hu, XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. statistical validation. Stroke 26: pp. 627-634 CrossRef
  15. Hao, HD, He, LR (2004) Mechanisms of cardiovascular protection by resveratrol. J Med Food 7: pp. 290-298 CrossRef
  16. Ichiyama, T, Kajimoto, M, Suenaga, N, Maeba, S, Matsubara, T, Furukawa, S (2006) Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. J Neuroimmunol 172: pp. 182-186 CrossRef
  17. Khan, M, Dhammu, TS, Sakakima, H, Shunmugavel, A, Gilg, AG, Singh, AK, Singh, I (2012) The inhibitory effect of S-nitrosoglutathione on blood鈥揵rain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. J Neurochem 123: pp. 86-97 CrossRef
  18. Lee, H, Park, JW, Kim, SP, Lo, EH, Lee, SR (2009) Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia. Neurobiol Dis 34: pp. 189-198 CrossRef
  19. Lin, YL, Chang, HC, Chen, TL, Chang, JH, Chiu, WT, Lin, JW, Chen, RM (2010) Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140: pp. 2187-2192 CrossRef
  20. Malemud, CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: pp. 1696-1701 CrossRef
  21. Marchal, J, Pifferi, F, Aujard, F (2013) Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span. Ann N Y Acad Sci 1290: pp. 67-73 CrossRef
  22. Olas, B, Saluk-Juszczak, J, Wachowicz, B (2008) D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. Cell Biol Toxicol 24: pp. 189-199 CrossRef
  23. Rahal, K, Schmiedlin-Ren, P, Adler, J, Dhanani, M, Sultani, V, Rittershaus, AC, Reingold, L, Zhu, J, McKenna, BJ, Christman, GM, Zimmermann, EM (2012) Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn鈥檚 disease. Inflamm Bowel Dis 18: pp. 613-623 CrossRef
  24. Raval, AP, Lin, HW, Dave, KR, Defazio, RA, Della, MD, Kim, EJ, Perez-Pinzon, MA (2008) Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15: pp. 1545-1551 CrossRef
  25. Rosenberg, GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39: pp. 279-291 CrossRef
  26. Rosenberg, GA, Estrada, EY, Dencoff, JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29: pp. 2189-2195 CrossRef
  27. Saha, A, Sarkar, C, Singh, SP, Zhang, Z, Munasinghe, J, Peng, S, Chandra, G, Kong, E, Mukherjee, AB (2012) The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol. Hum Mol Genet 21: pp. 2233-2244 CrossRef
  28. Sakata, Y, Zhuang, H, Kwansa, H, Koehler, RC, Dore, S (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224: pp. 325-329 CrossRef
  29. Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM, Hong Y. (2013) Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-kappaB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther
  30. Siflinger-Birnboim, A, Del, VP, Cooper, JA, Blumenstock, FA, Shepard, JM, Malik, AB (1987) Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 132: pp. 111-117 CrossRef
  31. Souvenir, R, Fathali, N, Ostrowski, RP, Lekic, T, Zhang, JH, Tang, J (2011) Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia. Neurobiol Dis 44: pp. 28-37 CrossRef
  32. Stetler-Stevenson, WG (2008) Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 1: pp. e6 CrossRef
  33. Tan, HK, Heywood, D, Ralph, GS, Bienemann, A, Baker, AH, Uney, JB (2003) Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22: pp. 98-106 CrossRef
  34. Wang, X, Barone, FC, White, RF, Feuerstein, GZ (1998) Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. Stroke 29: pp. 516-520 CrossRef
  35. Woo, MS, Park, JS, Choi, IY, Kim, WK, Kim, HS (2008) Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J Neurochem 106: pp. 770-780 CrossRef
  36. Xiong, L, Zheng, Y, Wu, M, Hou, L, Zhu, Z, Zhang, X, Lu, Z (2003) Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 96: pp. 233-237
  37. Zlokovic, BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: pp. 178-201 CrossRef
  
• 刊物主题：Neurosciences; Neurochemistry; Cell Biology; Proteomics; Neurology;
• 出版者：Springer US
• ISSN：1559-1166

文摘

The collapse of the blood-brain barrier (BBB) is one of the fundamental pathophysiology changes during cerebral ischemia reperfusion injury. Resveratrol has been recently reported to reduce cerebral ischemic damage by regulating the matrix metalloproteinase-9 (MMP-9). But, more direct evidence for the explanation of the BBB protected by resveratrol against cerebral ischemia reperfusion is still lacking. Therefore, the present study was aimed to investigate the regulation of BBB integrity by resveratrol after cerebral ischemia reperfusion and to determine the role of the MMP-9 and its endogenous inhibitor TIMP-1 balance in this process. Cerebral ischemia was induced by middle cerebral artery occlusion in rats. The BBB function was evaluated by brain water content and the Evans blue dye extravasation; the activities of MMP-9 and TIMP-1 were detected by using gelatin zymography analysis, and cellular apoptosis was examined by TUNEL staining. We confirmed that resveratrol reduced the cerebral ischemia reperfusion damage, brain edema, and Evans blue dye extravasation. Moreover, we found that resveratrol improved the balance of MMP-9/TIMP-1 in terms of their expressions and activities. A TIMP-1 neutralizing antibody reversed those neuroprotective effects of resveratrol. In conclusion, resveratrol attenuated the cerebral ischemia by maintaining the integrity of BBB via regulation of MMP-9 and TIMP-1.